Mobius Therapeutics
AcquiredThe Mitosol Kit for Ophthalmic Use - FDA Approved
- Business Model
- B2B
- Website
- mobiustherapeutics.com
About
Mobius Therapeutics focuses on ophthalmic perioperative pharmaceuticals and identifies challenging needs where new solutions can improve patient care, access, and provider safety. The company offers Mitosol, the first and only FDA-approved ophthalmic formulation of mitomycin C, as an adjunct to glaucoma surgery. Since becoming a wholly owned Glaukos subsidiary, it continues providing Mitosol with an emphasis on safety, quality, and innovation.
Summary
Mobius Therapeutics is a Healthcare company based in United States.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
China's leading blood products manufacturer
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/mobius-therapeutics"><img src="https://indexed.vc/api/badge/company/mobius-therapeutics" alt="Mobius Therapeutics on Indexed.vc" width="260" height="76" /></a>